TYK Medicines (HKSE:02410) Net Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02410 TYK Medicines Inc HKSE:02410
7 GF Score
Price HK$6.81
! 3 Warning Signs
View Full Analysis

What is TYK Medicines Net Margin %?

TYK Medicines HKSE:02410 -4.08% 7 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review. Among 943 Biotechnology companies, TYK Medicines ranks worse than 106044.43% on this metric.

Net margin is calculated as Net Income divided by its Revenue. TYK Medicines's Net Income for the six months ended in Dec. 2025 was HK$-207.24 Mil. TYK Medicines's Revenue for the six months ended in Dec. 2025 was HK$0.00 Mil. Therefore, TYK Medicines's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for TYK Medicines's Net Margin % or its related term are showing as below:


HKSE:02410's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

TYK Medicines  (HKSE:02410) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

TYK Medicines Net Margin % Related Terms

TYK Medicines Net Margin % Historical Data

* Premium members only.

The historical data trend for TYK Medicines's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines Net Margin % Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Margin %
-702.93 0.00 -362,404.39 0.00

TYK Medicines Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial 0.00 0.00 -157,249.12 0.00 0.00

HKSE:02410 vs VRTX, REGN, RVMD: Net Margin % Comparison

For the Biotechnology subindustry, TYK Medicines's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TYK Medicines Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TYK Medicines's Net Margin % distribution charts can be found below:

* The bar in red indicates where TYK Medicines's Net Margin % falls into.


HKSE:02410
7GF Score
TYK Medicines Inc HKSE:02410
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TYK Medicines Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

TYK Medicines's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-331.161/0
= %

TYK Medicines's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-207.236/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
TYK Medicines (HKSE:02410) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on TYK Medicines and its competitors. According to the industry distribution chart, TYK Medicines ranks #999999 out of 943 companies in the Biotechnology industry.
Is TYK Medicines' Net Margin % too high?
TYK Medicines' current Net Margin % is 0.00%. Based on the distribution chart, TYK Medicines ranks #999999 out of 943 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TYK Medicines ranks #999999 out of 943 companies for Net Margin %. This places TYK Medicines in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on TYK Medicines and its competitors. TYK Medicines's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TYK Medicines Business Description

Address No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score

Get the complete analysis for HKSE:02410

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.81
Price